Aβ and Tau proteins are the key factors to promote the progress of Alzheimer’s disease, their abnormal accumulation can cause cognitive impairment (Šimić et al., 2016; Sardar Sinha et al., 2018). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.